Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-21

Clinical Trial Update: Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan [Phase 2]

View source ↗

Summary

Phase 2 trial comparing different doses of rostafuroxin to losartan for antihypertensive effects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan (losartan)
  • Rostafuroxin (rostafuroxin)

Snippet

Sponsor: Windtree Therapeutics | Conditions: Hypertension | Phase 2 | Status: COMPLETED